Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics

NCT ID: NCT01371318

Last Updated: 2014-12-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

1609 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-07-31

Study Completion Date

2014-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether using the OWEMR as part of the standard of care for Diabetic Foot Ulcers reduces the rate of lower limb amputations and to quantify the relationship between glycemic control and the rate of amputation secondary to chronic foot ulcers in Type II Diabetes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Online Wound Electronic Medical Record (OWEMR) is a medical informatics tool that synthesizes data about complex wound problems from multiple sources and is innovative in its capability to performing these critical tasks: i) identification of the information needed to make treatment decisions at the point of care in real time ii) use intelligent search and report features to identify patients who require emergency interventions, and iii) provide evidence-based clinical decision support to clinicians. Use of the OWEMR includes digital photography as an objective measurement of wound healing rates.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Wounds Diabetes Complications Diabetic Foot Foot Ulcer

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

diabetic foot ulcer amputation wounds diabetic foot diabetes complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

OWEMR

Medical centers will be randomized to use the Online Wound Electronic Medical Record to enhance care of patients with diabetic foot ulcers

Group Type EXPERIMENTAL

Online Wound Electronic Medical Record

Intervention Type OTHER

Online Wound Electronic Medical Record is a medical informatics tool that synthesizes data about complex wound problems from multiple sources and is innovative in its capability to performing these critical tasks: i) identification of the information needed to make treatment decisions at the point of care in real time ii) use intelligent search and report features to identify patients who require emergency interventions, and iii) provide evidence-based clinical decision support to clinicians

Standard of Care

Medical/wound centers will be randomized to continue routine care of patients with diabetic foot ulcers

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Online Wound Electronic Medical Record

Online Wound Electronic Medical Record is a medical informatics tool that synthesizes data about complex wound problems from multiple sources and is innovative in its capability to performing these critical tasks: i) identification of the information needed to make treatment decisions at the point of care in real time ii) use intelligent search and report features to identify patients who require emergency interventions, and iii) provide evidence-based clinical decision support to clinicians

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Signed informed Consent
* Type I or II diabetes\*
* A break in the skin on the foot ≥ 0.5cm2
* 18 yrs of age or older
* Hemoglobin A1c value within the last 120 days
* No use of Investigational Agents /Devices on study or within 30 days prior to enrollment
* Subjects who will be locally available for the next 6 months
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Agency for Healthcare Research and Quality (AHRQ)

FED

Sponsor Role collaborator

NYU Langone Health

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Stephen Warren

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stephen M Warren, MD

Role: PRINCIPAL_INVESTIGATOR

NYU School of Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Phoenix VA Hospital

Phoenix, Arizona, United States

Site Status

University of Arizona

Tuscon, Arizona, United States

Site Status

Western University Health Sciences

Pomona, California, United States

Site Status

Georgetown University Medical Center

Washington D.C., District of Columbia, United States

Site Status

Memorial Healthcare System

Hollywood, Florida, United States

Site Status

Aiyan Diabetes Center

Evans, Georgia, United States

Site Status

Elks Wound Center

Meridian, Idaho, United States

Site Status

Mayo Clinic

Rochester, Minnesota, United States

Site Status

North Shore Long Island Jewish Health System

Lake Success, New York, United States

Site Status

Bellevue Hospital

New York, New York, United States

Site Status

Metropolitan Hospital

New York, New York, United States

Site Status

Lincoln Hospital

New York, New York, United States

Site Status

University of Texas Southwestern Medical Center

Dallas, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01HS019218-01

Identifier Type: AHRQ

Identifier Source: org_study_id

View Link